Scinai Immunotherapeutics Ltd. (SCNI)
0.483
-0.02
(-3.40%)
USD |
NASDAQ |
Jun 02, 16:00
0.483
0.00 (0.00%)
After-Hours: 20:00
Scinai Immunotherapeutics Enterprise Value : 7.851M for June 1, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Compugen Ltd. | 100.66M |
| Pluri, Inc. | 55.69M |
| Evogene Ltd. | 6.592M |
| CollPlant Biotechnologies Ltd. | 3.802M |
| Regentis Biomaterials Ltd. | 50.81M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.076M |
| Revenue (Quarterly) | 0.2636M |
| Total Expenses (Quarterly) | 2.340M |
| EPS Diluted (Quarterly) | -0.6037 |
| Profit Margin (Quarterly) | -787.5% |
| Earnings Yield | -1.85K% |
| Normalized Earnings Yield | -1374.37 |